{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:18:43Z","timestamp":1783718323501,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/WOS-B\/HN-32\/2021"],"award-info":[{"award-number":["DST\/WOS-B\/HN-32\/2021"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["OMI\/03\/2022\/ECD"],"award-info":[{"award-number":["OMI\/03\/2022\/ECD"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/14\/2024\/01-04170"],"award-info":[{"award-number":["EMDR\/SG\/14\/2024\/01-04170"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17404-4","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:18:02Z","timestamp":1756444682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human vaginal Lactobacillus Jensenii -derived (-)-Terpinen-4-ol restores antibiotic sensitivity by inhibiting efflux pumps in drug resistant E. coli and K. pneumoniae"],"prefix":"10.1038","volume":"15","author":[{"given":"Veena G","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineetha K","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraimathi","family":"Muralidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badri N S","family":"Venkatathri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene Christena","family":"Lowrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"YBRD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiviya","family":"Narbhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhusaran","family":"N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisubramanian","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"17404_CR1","first-page":"169","volume":"10","author":"S Reza Mortazavi-Tabatabaei","year":"2019","unstructured":"Reza Mortazavi-Tabatabaei, S. et al. Pattern of antibacterial resistance in urinary tract infections: A systematic review and meta-analysis. Int. J. Prev. Med. 10, 169 (2019).","journal-title":"Int. J. Prev. Med."},{"key":"17404_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12879-019-3880-z","volume":"19","author":"W-P Lin","year":"2019","unstructured":"Lin, W.-P., Huang, Y.-S., Wang, J.-T., Chen, Y.-C. & Chang, S.-C. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan. BMC Infect. Dis. 19, 245 (2019).","journal-title":"BMC Infect. Dis."},{"key":"17404_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.02448-17","volume":"9","author":"VI Band","year":"2018","unstructured":"Band, V. I. et al. Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected Colistin Heteroresistance leads to treatment failure in a murine model of infection. MBio 9, 10\u20131128 (2018).","journal-title":"MBio"},{"key":"17404_CR4","doi-asserted-by":"publisher","unstructured":"Embracing a One Health Framework to Fight Antimicrobial Resistance. (OECD, 2023). https:\/\/doi.org\/10.1787\/ce44c755-en.","DOI":"10.1787\/ce44c755-en"},{"key":"17404_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/dkg050","volume":"51","author":"MA Webber","year":"2003","unstructured":"Webber, M. A. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51, 9\u201311 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"17404_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","volume":"149","author":"A Sharma","year":"2019","unstructured":"Sharma, A., Gupta, V. & Pathania, R. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J. Med. Res. 149, 129 (2019).","journal-title":"Indian J. Med. Res."},{"key":"17404_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/viru.23724","volume":"4","author":"SM Soto","year":"2013","unstructured":"Soto, S. M. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 4, 223\u2013229 (2013).","journal-title":"Virulence"},{"key":"17404_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/pharmaceutics16020170","volume":"16","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Bacterial efflux pump inhibitors reduce antibiotic resistance. Pharmaceutics 16, 170 (2024).","journal-title":"Pharmaceutics"},{"key":"17404_CR9","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1038\/s41598-019-39659-4","volume":"9","author":"R Ferrer-Espada","year":"2019","unstructured":"Ferrer-Espada, R. et al. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains. Sci. Rep. 9, 3452 (2019).","journal-title":"Sci. Rep."},{"key":"17404_CR10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/jac\/dkl460","volume":"59","author":"M Stavri","year":"2007","unstructured":"Stavri, M., Piddock, L. J. V. & Gibbons, S. Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 59, 1247\u20131260 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"17404_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1139\/cjm-2014-0063","volume":"60","author":"GD Wright","year":"2014","unstructured":"Wright, G. D. Something old, something new: revisiting natural products in antibiotic drug discovery. Can. J. Microbiol. 60, 147\u2013154 (2014).","journal-title":"Can. J. Microbiol."},{"key":"17404_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1021\/np500775e","volume":"78","author":"KE Whalen","year":"2015","unstructured":"Whalen, K. E., Poulson-Ellestad, K. L., Deering, R. W., Rowley, D. C. & Mincer, T. J. Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione Isolated from a Pseudoalteromonas sp. J. Nat. Prod. 78, 402\u2013412 (2015).","journal-title":"J. Nat. Prod."},{"key":"17404_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0014-827X(01)01002-3","volume":"56","author":"MD Lee","year":"2001","unstructured":"Lee, M. D. et al. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Il Farmaco 56, 81\u201385 (2001).","journal-title":"Il Farmaco"},{"key":"17404_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1128\/AEM.00632-08","volume":"75","author":"ME Teasdale","year":"2009","unstructured":"Teasdale, M. E., Liu, J., Wallace, J., Akhlaghi, F. & Rowley, D. C. Secondary metabolites produced by the marine bacterium Halobacillus salinus that inhibit quorum sensing-controlled phenotypes in gram-negative bacteria. Appl. Environ. Microbiol. 75, 567\u2013572 (2009).","journal-title":"Appl. Environ. Microbiol."},{"key":"17404_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","volume":"11","author":"AJ Kunz Coyne","year":"2022","unstructured":"Kunz Coyne, A. J., El Ghali, A., Holger, D., Rebold, N. & Rybak, M. J. Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa. Infect. Dis. Ther. 11, 661\u2013682 (2022).","journal-title":"Infect. Dis. Ther."},{"key":"17404_CR16","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2174\/138161211795703726","volume":"17","author":"P Tegos","year":"2011","unstructured":"Tegos, P. et al. Microbial efflux pump inhibition: Tactics and strategies. Curr. Pharm. Des. 17, 1291\u20131302 (2011).","journal-title":"Curr. Pharm. Des."},{"key":"17404_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874285801307010034","volume":"7","author":"C Kourtesi","year":"2013","unstructured":"Kourtesi, C. et al. Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol. J. 7, 34\u201352 (2013).","journal-title":"Open Microbiol. J."},{"key":"17404_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/antibiotics12010167","volume":"12","author":"RA Watson","year":"2023","unstructured":"Watson, R. A. Enlisting probiotics to combat recurrent urinary tract infections in women\u2014a military strategy for meeting the challenge. Antibiotics 12, 167 (2023).","journal-title":"Antibiotics"},{"key":"17404_CR19","doi-asserted-by":"publisher","first-page":"15387","DOI":"10.1038\/s41598-024-65780-0","volume":"14","author":"VG Nair","year":"2024","unstructured":"Nair, V. G. et al. Biogenic amine tryptamine in human vaginal probiotic isolates mediates matrix inhibition and thwarts uropathogenic E. coli biofilm. Sci. Rep. 14, 15387 (2024).","journal-title":"Sci. Rep."},{"key":"17404_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/horticulturae9080911","volume":"9","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Antifungal activity of cell-free supernatants from Lactobacillus pentosus 86 against Alternaria gaisen. Horticulturae 9, 911 (2023).","journal-title":"Horticulturae"},{"key":"17404_CR21","doi-asserted-by":"publisher","first-page":"19845","DOI":"10.1038\/s41598-019-56325-x","volume":"9","author":"NS Sundaramoorthy","year":"2019","unstructured":"Sundaramoorthy, N. S., Suresh, P., Selva Ganesan, S., GaneshPrasad, A. & Nagarajan, S. Restoring colistin sensitivity in colistin-resistant E. coli: Combinatorial use of MarR inhibitor with efflux pump inhibitor. Sci. Rep. 9, 19845 (2019).","journal-title":"Sci. Rep."},{"key":"17404_CR22","doi-asserted-by":"publisher","first-page":"12899","DOI":"10.1039\/C4RA15382K","volume":"5","author":"LR Christena","year":"2015","unstructured":"Christena, L. R. et al. Copper nanoparticles as an efflux pump inhibitor to tackle drug resistant bacteria. RSC Adv. 5, 12899\u201312909 (2015).","journal-title":"RSC Adv."},{"key":"17404_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.micpath.2018.08.022","volume":"124","author":"NS Sundaramoorthy","year":"2018","unstructured":"Sundaramoorthy, N. S. et al. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo. Microb. Pathog. 124, 54\u201362 (2018).","journal-title":"Microb. Pathog."},{"key":"17404_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-2672.2000.00971.x","volume":"88","author":"IM Helander","year":"2000","unstructured":"Helander, I. M. & Mattila-Sandholm, T. Fluorometric assessment of Gram-negative bacterial permeabilization. J. Appl. Microbiol. 88, 213\u2013219 (2000).","journal-title":"J. Appl. Microbiol."},{"key":"17404_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183457","volume":"12","author":"AD Ogunniyi","year":"2017","unstructured":"Ogunniyi, A. D. et al. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent. PLoS ONE 12, e0183457 (2017).","journal-title":"PLoS ONE"},{"key":"17404_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156690","volume":"11","author":"A Grillon","year":"2016","unstructured":"Grillon, A., Schramm, F., Kleinberg, M. & Jehl, F. Comparative activity of ciprofloxacin, levofloxacin and moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia assessed by minimum inhibitory concentrations and time-kill studies. PLoS ONE 11, e0156690 (2016).","journal-title":"PLoS ONE"},{"key":"17404_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2005.11.021","volume":"243","author":"C-C Peng","year":"2006","unstructured":"Peng, C.-C., Chen, K.-C., Peng, R. Y., Su, C.-H. & Hsieh-Li, H. M. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts. Cancer Lett. 243, 109\u2013119 (2006).","journal-title":"Cancer Lett."},{"key":"17404_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fmicb.2015.00421","volume":"6","author":"TJ Opperman","year":"2015","unstructured":"Opperman, T. J. & Nguyen, S. T. Recent advances toward a molecular mechanism of efflux pump inhibition. Front. Microbiol. 6, 421 (2015).","journal-title":"Front. Microbiol."},{"key":"17404_CR29","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.3402\/ljm.v6i0.5870","volume":"6","author":"M Askoura","year":"2011","unstructured":"Askoura, M., Mattawa, W., Abujamel, T. & Taher, I. Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa. Libyan J. Med. 6, 5870 (2011).","journal-title":"Libyan J. Med."},{"key":"17404_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","volume":"19","author":"LJV Piddock","year":"2006","unstructured":"Piddock, L. J. V. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382\u2013402 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"17404_CR31","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1016\/S0021-9258(17)37154-5","volume":"269","author":"J Sikkema","year":"1994","unstructured":"Sikkema, J., de Bont, J. A. & Poolman, B. Interactions of cyclic hydrocarbons with biological membranes. J. Biol. Chem. 269, 8022\u20138028 (1994).","journal-title":"J. Biol. Chem."},{"key":"17404_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/jac\/dkn217","volume":"62","author":"I Couto","year":"2008","unstructured":"Couto, I., Costa, S. S., Viveiros, M., Martins, M. & Amaral, L. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J. Antimicrob. Chemother. 62, 504\u2013513 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"17404_CR33","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1080\/07391102.2017.1413424","volume":"36","author":"GR Dwivedi","year":"2018","unstructured":"Dwivedi, G. R. et al. Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa. J. Biomol. Struct. Dyn. 36, 4270\u20134284 (2018).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"17404_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/IDR.S156995","volume":"11","author":"I Ghai","year":"2018","unstructured":"Ghai, I. & Ghai, S. Understanding antibiotic resistance via outer membrane permeability. Infect. Drug Resist. 11, 523\u2013530 (2018).","journal-title":"Infect. Drug Resist."},{"key":"17404_CR35","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","volume":"1794","author":"AH Delcour","year":"2009","unstructured":"Delcour, A. H. Outer membrane permeability and antibiotic resistance. Biochim. et Biophysica Acta (BBA) - Proteins Proteomics 1794, 808\u2013816 (2009).","journal-title":"Biochim. et Biophysica Acta (BBA) - Proteins Proteomics"},{"key":"17404_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/08927014.2018.1504926","volume":"34","author":"EAF Bordini","year":"2018","unstructured":"Bordini, E. A. F. et al. Antimicrobial effects of terpinen-4-ol against oral pathogens and its capacity for the modulation of gene expression. Biofouling 34, 815\u2013825 (2018).","journal-title":"Biofouling"},{"key":"17404_CR37","doi-asserted-by":"publisher","first-page":"17629","DOI":"10.1038\/s41598-017-17772-6","volume":"7","author":"C Muheim","year":"2017","unstructured":"Muheim, C. et al. Increasing the permeability of Escherichia coli using MAC13243. Sci. Rep. 7, 17629 (2017).","journal-title":"Sci. Rep."},{"key":"17404_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11101-015-9436-y","volume":"14","author":"S Prasch","year":"2015","unstructured":"Prasch, S. & Bucar, F. Plant derived inhibitors of bacterial efflux pumps: an update. Phytochem. Rev. 14, 961\u2013974 (2015).","journal-title":"Phytochem. Rev."},{"key":"17404_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/fmb-2019-0204","volume":"15","author":"SK Bose","year":"2020","unstructured":"Bose, S. K., Chauhan, M., Dhingra, N., Chhibber, S. & Harjai, K. terpinen-4-ol attenuates quorum sensing regulated virulence factors and biofilm formation in Pseudomonas aeruginosa. Future Microbiol. 15, 127\u2013142 (2020).","journal-title":"Future Microbiol."},{"key":"17404_CR40","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1021\/acs.jafc.0c07826","volume":"69","author":"L Zhao","year":"2021","unstructured":"Zhao, L. et al. (+)-Terpinen-4-ol inhibits bacillus cereus biofilm formation by upregulating the interspecies quorum sensing signals diketopiperazines and diffusing signaling factors. J. Agric. Food Chem. 69, 3496\u20133510 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"17404_CR41","doi-asserted-by":"publisher","first-page":"9223","DOI":"10.1038\/s41598-019-45532-1","volume":"9","author":"Q Jia","year":"2019","unstructured":"Jia, Q. et al. Terpene synthase genes originated from bacteria through horizontal gene transfer contribute to Terpenoid diversity in fungi. Sci. Rep. 9, 9223 (2019).","journal-title":"Sci. Rep."},{"key":"17404_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00253-024-13048-y","volume":"108","author":"M Ma","year":"2024","unstructured":"Ma, M. et al. The microbial biosynthesis of noncanonical terpenoids. Appl. Microbiol. Biotechnol. 108, 226 (2024).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"17404_CR43","doi-asserted-by":"publisher","first-page":"7472","DOI":"10.3390\/molecules27217472","volume":"27","author":"B Johansen","year":"2022","unstructured":"Johansen, B., Duval, R. & Sergere, J.-C. First evidence of a combination of terpinen-4-ol and \u03b1-terpineol as a promising tool against ESKAPE pathogens. Molecules 27, 7472 (2022).","journal-title":"Molecules"},{"key":"17404_CR44","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.3390\/ijms21124531","volume":"21","author":"L Cordeiro","year":"2020","unstructured":"Cordeiro, L. et al. Terpinen-4-ol as an antibacterial and antibiofilm agent against Staphylococcus aureus. Int. J. Mol. Sci. 21, 4531 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"17404_CR45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.fct.2017.02.031","volume":"109","author":"PW Limaverde","year":"2017","unstructured":"Limaverde, P. W. et al. Inhibition of the TetK efflux-pump by the essential oil of Chenopodium ambrosioides L. and \u03b1-terpinene against Staphylococcus aureus IS-58. Food Chem Toxicol 109, 957\u2013961 (2017).","journal-title":"Food Chem Toxicol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17404-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:58:46Z","timestamp":1757455126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17404-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17404"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17404-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5122361\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have filed a patent describing a formulation containing (-)-Terpinen-4-ol and two other postbiotics derived from\n                      Lactobacilli\n                      to treat induced UTI in mice model (Patent Application Number: 202441057663; Reference Number: TEMP\/E-1\/67129\/2024-CHE). The collection of human vaginal samples was approved by the Human Ethical Committee (Registration number: 696\/TSRMMCH&RC\/ME-1\/2022-IEC No: 127), with adherence to all relevant international and national guidelines. Informed consent was obtained from all participants before enrolment. Zebrafish studies were conducted in line with national and institutional guidelines (CPCSEA-510\/SASTRA\/IAEC\/RPP) for the ethical treatment and use of animals, following Animal Biosafety Level 2 standards. To maintain the integrity of the histopathology study, the observer was blinded to the control and treatment groups.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"31823"}}